Novel Quinazolinone-Based 2,4-Thiazolidinedione-3-Acetic Acid Derivatives as Potent Aldose Reductase Inhibitors

Abstract

This work represents a promising matrix for developing new potential therapeutic candidates for prevention of diabetic complications through targeting aldose reductase enzyme. [Formula: see text].